Among patients diagnosed with AML-MR, other mutations in SF3B1, NRAS, ASXL1, SRSF2, FLT3, TET2, CBL, IDH1/2, DNMT3A, PHF6, PTPN11, JAK2, EZH2, BCOR, and TP53, were also observed. This evidence concerns the gene IDH1 and acute myeloid leukemia.